Baseline heterogeneity in glucose metabolism marks the risk for type 1 diabetes and complicates secondary prevention.
(2015) In Acta Diabetologica 52(3). p.473-481- Abstract
- Non-diabetic children with multiple islet autoantibodies were recruited to a secondary prevention trial. The objective was to determine the predictive value of baseline (1) HbA1c and metabolic variables derived from intravenous (IvGTT) and oral glucose tolerance tests (OGTT), (2) insulin resistance and (3) number, type and levels of islet autoantibodies, for progression to type 1 diabetes.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4817134
- author
- Larsson, Helena
LU
; Larsson, Christer LU and Lernmark, Åke LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Acta Diabetologica
- volume
- 52
- issue
- 3
- pages
- 473 - 481
- publisher
- Springer
- external identifiers
-
- pmid:25381193
- wos:000355233500006
- scopus:84930092396
- pmid:25381193
- ISSN
- 1432-5233
- DOI
- 10.1007/s00592-014-0680-1
- language
- English
- LU publication?
- yes
- id
- f6ed70d9-9f61-4eac-8bd5-39a5c28b0975 (old id 4817134)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25381193?dopt=Abstract
- date added to LUP
- 2016-04-01 10:40:51
- date last changed
- 2024-10-07 10:42:15
@article{f6ed70d9-9f61-4eac-8bd5-39a5c28b0975, abstract = {{Non-diabetic children with multiple islet autoantibodies were recruited to a secondary prevention trial. The objective was to determine the predictive value of baseline (1) HbA1c and metabolic variables derived from intravenous (IvGTT) and oral glucose tolerance tests (OGTT), (2) insulin resistance and (3) number, type and levels of islet autoantibodies, for progression to type 1 diabetes.}}, author = {{Larsson, Helena and Larsson, Christer and Lernmark, Åke}}, issn = {{1432-5233}}, language = {{eng}}, number = {{3}}, pages = {{473--481}}, publisher = {{Springer}}, series = {{Acta Diabetologica}}, title = {{Baseline heterogeneity in glucose metabolism marks the risk for type 1 diabetes and complicates secondary prevention.}}, url = {{https://lup.lub.lu.se/search/files/2047683/7449897.pdf}}, doi = {{10.1007/s00592-014-0680-1}}, volume = {{52}}, year = {{2015}}, }